Patents by Inventor William R. Thelin
William R. Thelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10968233Abstract: Provided are mucolytic agents represented by formula (Ia)-(Id): where the structural variables R1, R2, R5 and R6 are as defined herein. Also provided are a variety of methods of treatment which take advantage of the mucolytic properties of the compounds represented by formula (Ia)-(Id).Type: GrantFiled: September 5, 2018Date of Patent: April 6, 2021Assignee: PARION SCIENCES, INC.Inventors: Michael Ross Johnson, William R. Thelin
-
Patent number: 10526283Abstract: Provided are mucolytic compounds that are more effective, and/or absorbed less rapidly from mucosal surfaces, and/or are better tolerated as compared to N-acetylcysteine (NAC) and DTT. The compounds are represented by compounds of Formula I which embrace structures (Ia)-(Ib): where the structural variables are as defined herein.Type: GrantFiled: May 2, 2016Date of Patent: January 7, 2020Assignee: PARION SCIENCES, INC.Inventors: Michael Ross Johnson, William R. Thelin
-
Patent number: 10335558Abstract: Embodiments disclosed herein are directed to methods, compositions and apparatus for administering active agents to the lungs of a subject.Type: GrantFiled: June 2, 2014Date of Patent: July 2, 2019Assignee: PARION SCIENCES, INC.Inventors: Richard C. Boucher, Michael Ross Johnson, William R. Thelin, Brian Button, Tomas Navratil
-
Publication number: 20190031679Abstract: Provided are mucolytic agents represented by formula (Ia)-(Id): where the structural variables R1, R2, R5 and R6 are as defined herein. Also provided are a variety of methods of treatment which take advantage of the mucolytic properties of the compounds represented by formula (Ia)-(Id).Type: ApplicationFiled: September 5, 2018Publication date: January 31, 2019Inventors: Michael Ross JOHNSON, William R. THELIN
-
Patent number: 10106551Abstract: Provided are mucolytic agents represented by formula (Ia)-(Id): where the structural variables R1, R2, R5 and R6 are as defined herein. Also provided are a variety of methods of treatment which take advantage of the mucolytic properties of the compounds represented by formula (Ia)-(Id).Type: GrantFiled: January 29, 2016Date of Patent: October 23, 2018Assignee: PARION SCIENCES, INC.Inventors: Michael Ross Johnson, William R. Thelin
-
Patent number: 9963427Abstract: Provided are dithiol mucolytic agents. These agents increase the liquefaction of mucus in a patient with excessive mucus or mucus with increased viscoelastic, cohesive, or adhesive properties. Also provided are a variety of methods of treatment using these inventive mucolytic agents.Type: GrantFiled: March 11, 2016Date of Patent: May 8, 2018Assignee: PARION SCIENCES, INC.Inventors: Michael R. Johnson, William R. Thelin, Ronald A. Aungst, Jr.
-
Publication number: 20160318861Abstract: Provided are mucolytic compounds that are more effective, and/or absorbed less rapidly from mucosal surfaces, and/or are better tolerated as compared to N-acetylcysteine (NAC) and DTT. The compounds are represented by compounds of Formula I which embrace structures (Ia)-(Ib): where the structural variables are as defined herein.Type: ApplicationFiled: May 2, 2016Publication date: November 3, 2016Applicant: PARION SCIENCES, INC.Inventors: Michael Ross JOHNSON, William R. Thelin
-
Publication number: 20160222023Abstract: Provided are mucolytic agents represented by formula (Ia)-(Id): where the structural variables R1, R2, R5 and R6 are as defined herein. Also provided are a variety of methods of treatment which take advantage of the mucolytic properties of the compounds represented by formula (Ia)-(Id).Type: ApplicationFiled: January 29, 2016Publication date: August 4, 2016Applicant: PARION SCIENCES, INC.Inventors: Michael Ross JOHNSON, William R. THELIN
-
Publication number: 20160194278Abstract: Provided are dithiol mucolytic agents. These agents increase the liquefaction of mucus in a patient with excessive mucus or mucus with increased viscoelastic, cohesive, or adhesive properties. Also provided are a variety of methods of treatment using these inventive mucolytic agents.Type: ApplicationFiled: March 11, 2016Publication date: July 7, 2016Applicant: PARION SCIENCES, INC.Inventors: Michael R. JOHNSON, William R. THELIN, Ronald A. AUNGST, JR.
-
Patent number: 9346753Abstract: Provided are dithiol mucolytic agents. These agents increase the liquefaction of mucus in a patient with excessive mucus or mucus with increased viscoelastic, cohesive, or adhesive properties. Also provided are a variety of methods of treatment using these inventive mucolytic agents.Type: GrantFiled: August 13, 2014Date of Patent: May 24, 2016Assignee: PARION SCIENCES, INC.Inventors: Michael R. Johnson, William R. Thelin, Ronald A. Aungst, Jr.
-
Publication number: 20150307530Abstract: Provided is a method of liquefying mucus from mucosal surfaces by administering compounds containing a phosphine group.Type: ApplicationFiled: August 30, 2013Publication date: October 29, 2015Applicant: PARION SCIENCES, INC.Inventors: Michael R. JOHNSON, William R. THELIN, Richard C. BOUCHER, Diane VILLALON, Jone L. BOYER
-
Publication number: 20150101597Abstract: The present invention concerns methods, compositions and apparatus for administering active agents to the lungs of a subject.Type: ApplicationFiled: June 2, 2014Publication date: April 16, 2015Applicant: PARION SCIENCES, INC.Inventors: Richard C. BOUCHER, Michael Ross JOHNSON, William R. THELIN, Brian BUTTON, Tomas NAVRATIL
-
Publication number: 20150056305Abstract: Provided are dithiol mucolytic agents. These agents increase the liquefaction of mucus in a patient with excessive mucus or mucus with increased viscoelastic, cohesive, or adhesive properties. Also provided are a variety of methods of treatment using these inventive mucolytic agents.Type: ApplicationFiled: August 13, 2014Publication date: February 26, 2015Applicant: PARION SCIENCES, INC.Inventors: Michael R. Johnson, William R. Thelin, Ronald A. Aungst, JR.
-
Patent number: 8778383Abstract: The present invention concerns methods, compositions and apparatus for administering active agents to the lungs of a subject.Type: GrantFiled: June 7, 2012Date of Patent: July 15, 2014Assignee: Parion Sciences, Inc.Inventors: Richard C. Boucher, Michael Ross Johnson, William R. Thelin, Brian Button, Tomas Navratil
-
Publication number: 20130074842Abstract: The present invention concerns methods, compositions and apparatus for administering active agents to the lungs of a subject.Type: ApplicationFiled: June 7, 2012Publication date: March 28, 2013Inventors: Richard C. Boucher, Michael Ross Johnson, William R. Thelin, Brian Button, Tomas Navratil
-
Publication number: 20100074881Abstract: A device for administering two or more therapeutic agents simultaneously, comprising two or more nebulizers and a single connector linking the nebulizers to a nebulizer mouthpiece. Also provided is a method of administering two or more therapeutic agents simultaneously, comprising administering the therapeutic agents simultaneously with the device of the present invention to a subject in need thereof.Type: ApplicationFiled: July 13, 2009Publication date: March 25, 2010Applicant: PARION SCIENCES, Inc.Inventors: Richard C. BOUCHER, Michael R. Johnson, Keith A. Johnson, William R. Thelin